| Q33844319 | A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. |
| Q46861649 | A comparison of the effectiveness of single-dose vs multi-dose antenatal corticosteroids in pre-term neonates |
| Q28679318 | A pig model of the preterm neonate: anthropometric and physiological characteristics |
| Q34224396 | A psychoneuroimmunologic examination of cumulative perinatal steroid exposures and preterm infant behavioral follow-up |
| Q44543862 | A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis. |
| Q41779966 | Administration of dexamethasone to neonatal rats induces hypomyelination and changes in the morphology of oligodendrocyte precursors |
| Q34002905 | Animal models for small for gestational age and fetal programming of adult disease. |
| Q35394099 | Antenatal betamethasone alters vascular reactivity in adult female ovine cerebral arteries |
| Q36761894 | Antenatal corticosteroid prescribing: a complete audit cycle |
| Q30883529 | Antenatal corticosteroid therapy for fetal maturation. |
| Q47693864 | Antenatal corticosteroids administration: are we giving them at the right time? |
| Q35625274 | Antenatal corticosteroids for fetal maturation in women at risk for preterm delivery |
| Q46107588 | Antenatal corticosteroids for preterm birth: dose-dependent reduction in birthweight, length and head circumference. |
| Q34510328 | Antenatal corticosteroids in women with preterm premature rupture of the membranes |
| Q42786051 | Antenatal corticosteroids to prevent neonatal respiratory distress syndrome. We do not know whether repeated doses are better than a single dose |
| Q35864656 | Antenatal corticosteroids: a risk factor for the development of chronic disease |
| Q95324201 | Antenatal corticosteroids: is more better? |
| Q42930296 | Antenatal corticosteroids: neonatal effects of a second course |
| Q44200358 | Antenatal dexamethasone: effect on ovine placental 11beta-hydroxysteroid dehydrogenase type 2 expression and fetal growth |
| Q34021240 | Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial |
| Q37505163 | Antenatal glucocorticoid treatment affects hippocampal development in mice |
| Q33858306 | Antenatal glucocorticoids and programming of the developing CNS. |
| Q36497370 | Antenatal steroid therapy: have we undervalued the risks? |
| Q36440253 | Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses? |
| Q34010782 | Antenatal steroids and the developing brain |
| Q37665947 | Antenatal steroids: can we optimize the dose? |
| Q28218219 | Anti-inflammatory and immunosuppressive drugs and reproduction |
| Q46202711 | Are antenatal steroids beneficial to severely growth restricted fetuses? |
| Q37209067 | Association between birth weight and DNA methylation of IGF2, glucocorticoid receptor and repetitive elements LINE-1 and Alu. |
| Q34846771 | Auditory neural maturation after exposure to multiple courses of antenatal betamethasone in premature infants as evaluated by auditory brainstem response |
| Q44458234 | Brainstem maturation after antenatal steroids exposure in premature infants as evaluated by auditory brainstem-evoked response |
| Q40479808 | Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. |
| Q37168096 | Cardiac effects of a single course of antenatal betamethasone in preterm infants |
| Q35844008 | Carney's complex: a successful pregnancy after bilateral adrenalectomy. |
| Q34638829 | Causal ACTH-Depot Therapy during Pregnancies following Infertility Treatment |
| Q30475625 | Challenges to maternal wellbeing during pregnancy impact temperament, attention, and neuromotor responses in the infant rhesus monkey |
| Q64085218 | Combined antenatal and postnatal steroid effects on fetal and postnatal growth, and neurological outcomes in neonatal rats |
| Q51902994 | Comparative development of surviving co-twins of vanishing twin conceptions, twins and singletons. |
| Q37611448 | Comparison of single and double courses of antenatal corticosteroid administration on neonatal mortality and morbidity |
| Q51724159 | Comparison of single and repeated antenatal corticosteroid therapy to prevent neonatal death and morbidity in the preterm infant. |
| Q44632044 | Cortisol enhances structural maturation of the hypoplastic fetal lung in sheep |
| Q39833850 | Cortisol levels in pregnancy as a psychobiological predictor for birth weight |
| Q34353377 | Cumulative perinatal steroids: child development of preterm infants |
| Q35167355 | Current perspectives on the prevention and management of chronic lung disease in preterm infants |
| Q50493497 | Developmental outcome, child behaviour and mother-child interaction at 3 years of age following Newborn Individualized Developmental Care and Intervention Program (NIDCAP) intervention. |
| Q26822770 | Developmental perturbation induced by maternal asthma during pregnancy: the short- and long-term impacts on offspring |
| Q37142064 | Developments in the pharmacotherapeutic management of spontaneous preterm labor |
| Q48465526 | Dexamethasone prevents long-lasting learning impairment following neonatal hypoxic-ischemic brain insult in rats |
| Q45195076 | Diffusion-weighted MR imaging of fetal lung maturation in sheep: effect of prenatal cortisone administration on ADC values |
| Q36905447 | Diurnal salivary cortisol patterns prior to pregnancy predict infant birth weight |
| Q43273926 | Do alterations in placental 11beta-hydroxysteroid dehydrogenase (11betaHSD) activities explain differences in fetal hypothalamic-pituitary-adrenal (HPA) function following periconceptional undernutrition or twinning in sheep? |
| Q34798339 | Do we use too much antenatal betamethasone? |
| Q33625842 | Dose-response effects of betamethasone on maturation of the fetal sheep lung |
| Q38719903 | Effect of Betamethasone on Fetal Pulmonary and Umbilical Artery Doppler Velocimetry and Relationship With Respiratory Distress Syndrome Development |
| Q33625146 | Effect of antenatal betamethasone on maternal and fetal amino acid concentration. |
| Q47208374 | Effect of antenatal corticosteroids on postmortem brain weight of preterm babies |
| Q35770011 | Effect of corticosteroids on cardiac function in growth-restricted fetuses. |
| Q73011146 | Effect of dexamethasone treatment on maturational changes in the NMDA receptor in sheep brain |
| Q35558465 | Effect of insulin and dexamethasone on fetal assimilation of maternal glucose |
| Q33556952 | Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation |
| Q46567645 | Effect of pro-inflammatory cytokines on expression and activity of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human term placental trophoblast and human choriocarcinoma JEG-3 cells |
| Q34211845 | Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants. |
| Q34540613 | Effects of cortisol and dexamethasone on insulin signalling pathways in skeletal muscle of the ovine fetus during late gestation |
| Q35133763 | Effects of glucocorticoid exposure on growth and structural maturation of the heart of the preterm piglet |
| Q35072532 | Effects of intra-amniotic lipopolysaccharide and maternal betamethasone on brain inflammation in fetal sheep |
| Q37204773 | Elevated glucocorticoids during ovine pregnancy increase appetite and produce glucose dysregulation and adiposity in their granddaughters in response to ad libitum feeding at 1 year of age. |
| Q46835016 | Endotoxin-induced hypoxic-ischemic tolerance is mediated by up-regulation of corticosterone in neonatal rat. |
| Q35574905 | Etiology of cerebral palsy |
| Q36811513 | European consensus guidelines on the management of neonatal respiratory distress syndrome |
| Q58577716 | Excess Hydrocortisone Hampers Placental Nutrient Uptake Disrupting Cellular Metabolism |
| Q34127008 | Feed allowance and maternal backfat levels during gestation influence maternal cortisol levels, milk fat composition and offspring growth |
| Q46312890 | Fetal and neonatal outcomes after term and preterm delivery following betamethasone administration |
| Q44718040 | Fetal betamethasone treatment and neonatal outcome in preeclampsia and intrauterine growth restriction |
| Q34585150 | Fetal pharmacotherapy |
| Q50918704 | Fetal programming of temperamental negative affectivity among children born healthy at term. |
| Q64239944 | Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE) |
| Q37467891 | Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. |
| Q37668757 | Gestational age-specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor |
| Q36557730 | Glucocorticoid "programming" and PTSD risk |
| Q37013589 | Glucocorticoids, developmental 'programming' and the risk of affective dysfunction |
| Q37768957 | Glucocorticoids, prenatal stress and the programming of disease |
| Q37573929 | Growth and insulin dynamics in two generations of female offspring of mothers receiving a single course of synthetic glucocorticoids |
| Q37643149 | Histochemical analyses of altered fetal lung development following single vs multiple courses of antenatal steroids |
| Q37352945 | Impact of timing of antenatal corticosteroid exposure on neonatal outcomes |
| Q38737743 | In Utero Origins of Hypertension: Mechanisms and Targets for Therapy |
| Q35994309 | In utero glucocorticoid exposure reduces fetal skeletal muscle mass in rats independent of effects on maternal nutrition |
| Q73389030 | Inflammatory bowel disease during pregnancy |
| Q64107178 | Influence of Low Protein Diet-Induced Fetal Growth Restriction on the Neuroplacental Corticosterone Axis in the Rat |
| Q36263268 | Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole. |
| Q43166019 | Intestinal hormones and growth factors: effects on the small intestine |
| Q35786756 | Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs |
| Q43795757 | Is prenatal glucocorticoid administration another origin of adult disease? |
| Q33677228 | Kelch-like ECT2-interacting protein KLEIP regulates late-stage pulmonary maturation via Hif-2α in mice |
| Q44598208 | Late-gestation betamethasone enhances coronary artery responsiveness to angiotensin II in fetal sheep |
| Q46152691 | Late-pregnancy salivary cortisol concentrations of Ghanaian women participating in a randomized controlled trial of prenatal lipid-based nutrient supplements |
| Q51973290 | Linear hyperechogenicity within the basal ganglia and thalamus of preterm infants. |
| Q34224924 | Management and monitoring of severe preeclampsia |
| Q35878799 | Maternal Dexamethasone Treatment Alters Tissue and Circulating Components of the Renin-Angiotensin System in the Pregnant Ewe and Fetus |
| Q36089677 | Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour |
| Q44590574 | Maternal asthma is associated with reduced female fetal growth. |
| Q35103139 | Maternal baicalin treatment increases fetal lung surfactant phospholipids in rats |
| Q92183304 | Maternal cortisol during pregnancy and offspring schizophrenia: Influence of fetal sex and timing of exposure |
| Q44182971 | Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries |
| Q50284593 | Maternal hormonal milieu influence on fetal brain development |
| Q34093314 | Maternal mental disorders in pregnancy and the puerperium and risks to infant health |
| Q44757246 | Maternally administered dexamethasone at 0.7 of gestation suppresses maternal and fetal pituitary and adrenal responses to hypoxemia in sheep |
| Q36565762 | Measurement of betamethasone concentration in maternal serum treated for fetal lung maturity; Is it feasible? |
| Q36827835 | Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology |
| Q35738761 | Mechanisms of fetal programming in hypertension |
| Q34675817 | Mechanisms of non-genetic inheritance and psychiatric disorders |
| Q36579868 | Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review |
| Q51723921 | More reasons to hold on additional doses of antenatal steroids. |
| Q37088417 | Multigenerational effects of fetal dexamethasone exposure on the hypothalamic-pituitary-adrenal axis of first- and second-generation female offspring |
| Q48008930 | Multiple courses of antenatal corticosteroid therapy in patients with preterm premature rupture of membranes |
| Q46351730 | Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates |
| Q33989097 | Multiple courses of antenatal glucocorticoid treatment and fetal outcome |
| Q46339323 | Multiple courses of antenatal steroids |
| Q44115215 | Multiple versus single courses of antenatal corticosteroids for preterm birth: a pilot study |
| Q47366160 | Neonatal morbidity and growth in very low birth-weight infants after multiple courses of antenatal steroids |
| Q48203354 | Neonatal neuronal apoptosis after betamethasone administration in pregnant Wistar rats. |
| Q53254274 | Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. |
| Q30461149 | Neurobehavioral risk is associated with gestational exposure to stress hormones |
| Q34462370 | Neurodevelopment of children exposed in utero to treatment of maternal malignancy. |
| Q47405400 | Neurodevelopmental outcome of very low birth weight infants after multiple courses of antenatal corticosteroids |
| Q50558742 | New challenges beyond nutrition: c-section, air pollution and domestic violence. |
| Q35638156 | Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero |
| Q33941213 | Oxidative stress in the developing brain: effects of postnatal glucocorticoid therapy and antioxidants in the rat. |
| Q56381178 | Persistent Zika virus infection in porcine conceptuses is associated with elevated in utero cortisol levels |
| Q44718023 | Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration |
| Q35137631 | Placental endothelial nitric oxide synthase in multiple and single dose betamethasone exposed pregnancies |
| Q37810812 | Potential programming of dopaminergic circuits by early life stress |
| Q37190719 | Potential significance of physiological and pharmacological glucocorticoids in early pregnancy |
| Q42045709 | Preemies on steroids: a new iatrogenic disaster? |
| Q36570988 | Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies |
| Q46220124 | Prematurity is related to high placental cortisol in preeclampsia |
| Q34524486 | Prenatal corticosteroid impact on hippocampus: implications for postnatal outcomes. |
| Q37373308 | Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms |
| Q51306605 | Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. |
| Q46890923 | Prenatal exposure to betamethasone decreases anxiety in developing rats: hippocampal neuropeptide y as a target molecule |
| Q43197436 | Prenatal synthetic glucocorticoid exposure alters hypothalamic-pituitary-adrenal regulation and pregnancy outcomes in mature female guinea pigs |
| Q57477505 | Preterm birth: avenues for future study |
| Q43189372 | Preterm birth: effect of corticosteroids or immediate cord clamping? |
| Q36455265 | Psychobiological effects of prenatal glucocorticoid exposure in 10-year-old-children |
| Q38430681 | Regulation of lung development and regeneration by the vascular system |
| Q34395965 | Relationship between birthweight and repeated courses of antenatal corticosteroids |
| Q24186565 | Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes |
| Q24236327 | Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes |
| Q24243967 | Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease |
| Q57311273 | Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best l |
| Q30459633 | Repeated antenatal corticosteroid treatments adversely affect neural transmission time and auditory thresholds in laboratory rats |
| Q36638947 | Repeated courses of antenatal corticosteroids have adverse effects on aspects of brain development in naturally delivered baboon infants |
| Q30473352 | Repeated courses of antenatal corticosteroids: are there effects on the infant's auditory brainstem responses? |
| Q35147162 | Repeated courses of antenatal corticosteroids: is it justified? |
| Q43621447 | Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. |
| Q78344702 | Single versus multiple courses of antenatal corticosteroids |
| Q47315380 | Small body size at birth and behavioural symptoms of ADHD in children aged five to six years |
| Q37923498 | Stress, glucocorticoids and liquorice in human pregnancy: programmers of the offspring brain |
| Q44880447 | Surfactant metabolism and anti-oxidative capacity in hyperoxic neonatal rat lungs: effects of keratinocyte growth factor on gene expression in vivo. |
| Q89819834 | Targeting the Stress System During Gestation: Is Early Handling a Protective Strategy for the Offspring? |
| Q38641374 | The clinical use of corticosteroids in pregnancy. |
| Q47148533 | The effects of antenatal corticosteroid treatment on IVH-PVh of premature infants. |
| Q61846978 | The effects of intrauterine growth restriction and antenatal glucocorticoids on ovine fetal lung development |
| Q43771537 | The effects of repeated antenatal glucocorticoid therapy on the developing brain |
| Q34377634 | The impact of corticosteroids on the developing animal |
| Q38177398 | The impact of early nutrition on the ageing trajectory |
| Q36736411 | The impact of gestational stress and prenatal growth on emotional problems in offspring: a review. |
| Q33294494 | The impact of maternal experience of violence and common mental disorders on neonatal outcomes: a survey of adolescent mothers in Sao Paulo, Brazil |
| Q36751536 | The management of preterm labour |
| Q36817358 | The need to go beyond: evaluating antenatal corticosteroid trials with long-term outcomes |
| Q34804428 | The role of prenatal stress in the etiology of developmental behavioural disorders |
| Q40491415 | The specific and combined role of domestic violence and mental health disorders during pregnancy on new-born health. |
| Q33755588 | The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development |
| Q88796663 | The window of improved neonatal respiratory compliance after rescue antenatal steroids |
| Q32177958 | Timing of delivery in a high-risk obstetric population: a clinical prediction model |
| Q33778595 | Timing of fetal exposure to stress hormones: effects on newborn physical and neuromuscular maturation |
| Q40195867 | Transient catabolic state with reduced IGF-I after antenatal glucocorticoids |
| Q37316535 | Treating fetal thyroid and adrenal disorders through the mother |
| Q35979920 | Undesired effects of steroids during pregnancy. |
| Q35579232 | Use and misuse of corticosteroids |
| Q33198560 | Use of steroids in the perinatal period. |
| Q36365408 | Use of systemic glucocorticosteroids in pregnancy: be alert but not alarmed |
| Q38820342 | What we have learned about antenatal corticosteroid regimens |
| Q73726952 | [Fetuses, neonates and corticoids] |